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What can dissaving tell us about catastrophic
costs? Linear and logistic regression analysis
of the relationship between patient costs and
financial coping strategies adopted by
tuberculosis patients in Bangladesh, Tanzania
and Bangalore, India
Jason Madan1,2*, Knut Lönnroth3,4, Samia Laokri5,6 and Stephen Bertel Squire2,7,6
Abstract
Background: Tuberculosis (TB) is a major global public health problem which affects poorest individuals the worst.
A high proportion of patients incur ‘catastrophic costs’ which have been shown to result in severe financial
hardship and adverse health outcomes. Data on catastrophic cost incidence is not routinely collected, and current
definitions of this indicator involve several practical and conceptual barriers to doing so. We analysed data from TB
programmes in India (Bangalore), Bangladesh and Tanzania to determine whether dissaving (the sale of assets or
uptake of loans) is a useful indicator of financial hardship.
Methods: Data were obtained from prior studies of TB patient costs in Bangladesh (N = 96), Tanzania (N = 94) and
Bangalore (N = 891). These data were analysed using logistic and linear multivariate regression to determine the
association between costs (absolute and relative to income) and both the presence of dissaving and the amounts
dissaved.
Results: After adjusting for covariates such as age, sex and rural/urban location, we found a significant positive
association between the occurrence of dissaving and total costs incurred in Tanzania and Bangalore. We further
found that, for patients in Bangalore an increase in dissaving of $10 USD was associated with an increase in the
cost-income ratio of 0.10 (p < 0.001). For low-income patients in Bangladesh, an increase in dissaving of $10 USD
was associated with an increase in total costs of $7 USD (p <0.001).
Conclusions: Dissaving is potentially a convenient proxy for catastrophic costs that does not require usage of
complex patient cost questionnaires. It also offers an informative indicator of financial hardship in its own right, and
could therefore play an important role as an indicator to monitor and evaluate the impact of financial protection
and service delivery interventions in reducing hardship and facilitating universal health coverage. Further research is
required to understand the patterns and types of dissaving that have the strongest relationship with financial
hardship and clinical outcomes in order to move toward evidence-based policy making.
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Background
Health care utilisation can lead to severe financial hard-
ship, particularly for poorer households in low and mid-
dle income countries (LMICs). Hardship can arise even
when care is ‘free’, due to direct costs such as transport
and medication, and indirect costs (loss of income) [1].
Over 100 million individuals are pushed into poverty an-
nually by health costs [2]. Reducing healthcare-related
impoverishment, through improved design of healthcare
services and access to financial protection [3], is essen-
tial for the progressive realization of universal health
coverage [4]. The term ‘catastrophic health expenditure’
is commonly used to refer to direct healthcare costs that
place excessive burdens on households. Health expend-
iture is said to be catastrophic if it ‘threatens a house-
hold’s ability to meet its subsistence needs’ [5–7]. Some
have argued for a complementary indicator including
direct non-medical costs and income, as these can be at
least as problematic as direct medical costs [3, 8]. Cata-
strophic costs have been shown to be associated with
adverse clinical outcomes in tuberculosis (TB) [9]. In
recognition of the problem of costs faced by patients
with TB [8, 10, 11], the World Health Organisation has
adopted a post-2015 target of “no tuberculosis-affected
household facing catastrophic costs due to tuberculosis”
by 2020 [12].
Definition and measurement of catastrophic costs are
important to support the evaluation and monitoring of
both service delivery [13] and financial protection [14]
interventions. Despite this, data on the financial burden
of diseases such as TB impose on patients and their
households, and the incidence of catastrophic costs, are
not routinely collected. Unfortunately, standard defini-
tions of catastrophic costs, based on cost-income ratios,
create significant challenges for routine monitoring and
evaluation. In practice, catastrophic costs are commonly
defined as a threshold percentage of income or usual ex-
penditure, as this relates costs to the financial capacity of
a household. A range of thresholds have been used to de-
note catastrophic healthcare expenditure, such as >40 %
of discretional income [15] or >10 % of total income [16].
There are no established thresholds for total costs, al-
though a cut-off of >20 % of household income has been
suggested specifically for people receiving care for tuber-
culosis, based on an association with poor treatment
outcomes [9]. Calculation of patient costs involves the
completion of questionnaires which may be cumbersome
for routine use in monitoring and evaluation. Income may
be challenging to assess for the most disadvantaged pa-
tient groups, who rely on a range of activities generating
cash and in-kind income that is irregular and subject to
seasonal fluctuation. An alternative ‘proxy means’ ap-
proach can be used in which living circumstances and
possession of key items are used to classify socioeconomic
status [17], but such measures can only provide an ap-
proximation to current household income.
Given these challenges, directly measurable proxy in-
dicators of catastrophic costs would be beneficial. Low-
income households often take out loans or sell assets to
finance health-related expenditure [18]. This is some-
times referred to as ‘dissaving’, particularly in the eco-
nomics literature, to highlight the fact that it reduces the
financial strength of a household, just as saving increases
a household’s resilience to financial shocks [19]. Assets
are an important mechanism for saving in low income
households, who may not have access to any type of finan-
cial institution, formal or informal [20]. Where households
do have access to loans, the effects on household liveli-
hoods can be severe and long-lasting [21]. For such house-
holds, dissaving is easier to measure than expenditure and
income, and is likely to be associated with financial hard-
ship. To explore the potential for using dissaving as a
proxy indicator for catastrophic cost, we analysed the
association between patient costs and dissaving for pa-
tients receiving tuberculosis treatment in India (Bangalore),
Bangladesh and Tanzania.
Methods
Data for Bangladesh and Tanzania were collected as a
part of a study examining the potential financial impact
of shorter TB treatment regimens [13]. Data on income,
direct and indirect patient costs, asset sales, and loans
were collected in 2011/2012 for 96 patients in Bangladesh
and 94 patients in Tanzania, using a standard tuberculosis
patient costing questionnaire [22]. Patients were selected
to provide a representative sample of the population of
adult TB patients in each country, using a sampling strat-
egy described in detail in previous work [13]. Data were
collected in the first 2 months and the last 2 months of
treatment. Respondents were not asked their exact in-
come; instead, they were asked in which of four pre-
specified ranges their income lay. Additional questions on
household structure, dwelling construction, and durable
good ownership were used to compute Socioeconomic
Scores (SES) based on statistics from Demographic and
Household Surveys (DHS). Data for India were collected
to assess costs incurred by all patients (N = 1106)
newly registered for treatment in the city of Bangalore in
2005 under the Revised National tuberculosis Control
Programme (RNTCP) [23]. Patients completed question-
naires, at the start and end of treatment, on direct and in-
direct costs, income, loans, and amounts raised through
asset sales. SES were calculated using a standard-of-living
instrument previously used in several studies of the socio-
economic status of Indian tuberculosis patients. The costs
included in both studies were-transportation from and
to health facilities, medicines, food consumed during
the visit, and facility fees. Data was also collected in
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Bangladesh and Tanzania on costs for food supple-
ments taken on medical advice and accommodation
(if required). These two items were not specifically in-
cluded in the Bangalore questionnaire, although an option
was included to provide ‘other’ costs incurred by patients.
Cost and income data were measured in local currencies
in each study and translated to United States Dollars
(USD) assuming 45INR (Indian Rupees), 1570TZS
(Tanzanian Shillings) and 80BDT (Bangladeshi Taka)
per USD. Further details on the methods and the re-
sults from these studies have been reported elsewhere
[13, 23, 24]. As this was a retrospective study, ethics
approval was not required.
We reanalysed these patient cost datasets to explore
the determinants of high or extreme costs and the rela-
tionship between costs and dissaving. SBS and KL were
actively involved in the studies which collected these
datasets, and granted access to JM to permit this re-
analysis. We examined the distribution of costs relative
to the median in each study, to identify potential drivers
of high costs. We chose median costs as a convenient
benchmark for the typical costs faced by participants in
each study location. We chose to label costs ‘low’ if
below the median value, ‘medium’ if greater than median
but less than double the median, ‘high’ if greater than
double median costs but less than triple, and ‘extreme’ if
greater than triple median costs. These cut-off levels,
though arbitrary, allow us to explore the extent of atyp-
ically high costs in a comparable way across locations.
We carried out logistic and linear regression analyses to
determine the relationship between costs and the pres-
ence and amount of dissaving. For the Bangalore dataset,
we carried out additional regression analyses of the rela-
tionship between the level of dissaving and the cost/
income ratio, to assess the coincidence of dissaving
with ratio-based definitions of catastrophic cost. For the
Bangladesh and Tanzania datasets, we performed separate
regression analyses of the cost-dissaving relationship for
those whose reported income is low, high or missing,
as exact incomes were not reported. The explanatory
variables considered in the analyses were cost, SES,
location, age, gender and hospitalisation. All statistical
analyses were carried out in R version 3.0.1.
Results
Mean patient costs were considerably higher than me-
dian costs for all locations (40 % higher for Bangladesh
and Tanzania, 85 % higher in Bangalore), reflecting a
skewed distribution commonly found for costs. The re-
sults of our cost stratification are presented in Tables 1,
2 and 3. Cost data were provided by 891 (81 %) partici-
pants in Bangalore, and all participants in Bangladesh
and Tanzania. The proportion of patients experiencing
‘extreme’ costs varied across locations - 18 % in Banga-
lore (n = 157), 10 % in Tanzania (n = 9), and 3 % in
Bangladesh (n = 3). Patients experiencing extreme costs in
Bangalore were more likely to be male (p < 0.01), and were
more likely to report hospitalisation (p < 0.01), medium/
high SES (p < 0.01) and dissaving (p < 0.01). Given the low
numbers experiencing extreme costs in the other two
sites, a more instructive comparison is between those who
experience costs greater than 200 % of the median (i.e.
‘high’ or ‘extreme’ costs), and those who do not. The pro-
portion experiencing ‘high’ or ‘extreme’ costs was 18 % in
Bangladesh (N = 17) and 22 % in Tanzania (N = 21). In
Tanzania, costs greater than 200 % of the median were
significantly associated with hospitalisation (p < 0.01),
whereas in Bangladesh, they was significantly associated
with income in the higher band (p = 0.03).
Dissaving rates overall were comparable between
Tanzania and Bangladesh (61 % vs 55 %), and lower in
Bangalore(37 %). This difference was largely due to dis-
saving rates in the low cost band, which were lower in
Bangalore (19 %, vs 50 % in Bangladesh and 49 % in
Tanzania). Only 6 % of dissavers in Bangladesh and 5 %
in Bangalore relied solely on asset sales to raise funds. In
Bangladesh, assets were only sold where costs were low
or medium (i.e. less than 200 % of the median), whereas
there was no clear relationship between costs and type of
dissaving in Bangalore. Assets sales were more prevalent
Table 1 Information on dissaving and patient characteristics for Bangladesh tuberculosis patients, stratified by cost band
Cost
band
Definition No. Mean patient
cost (BDT)
%
Rural
Mean
age
%
Male
Mean SES
score
No. reporting
high income
No.
hospitalised
No. dissaving
Loan Sale Both All
Low <100 % of
median
48 4400 71 % 42 58 % −0.097 9 (19 %) 1 (2 %) 18 (38 %) 2 (4 %) 4 (8 %) 24 (50 %)
Medium 100–200 % of
median
33 12,100 74 % 42 76 % −0.085 6 (18 %) 3 (9 %) 13 (39 %) 1 (3 %) 5 (15 %) 19 (58 %)
High 200–300 % of
median
12 18,700 67 % 34 64 % 0.258 7 (58 %) 1 (7 %) 7 (58 %) 0 (0 %) 0 (0 %) 7 (58 %)
Extreme >300 % of
median
3 99,400 33 % 41 67 % 1.233 1 (33 %) 2 (67 %) 3 (100 %) 0 (0 %) 0 (0 %) 3 (100 %)
All Any cost level 96 11,700 70 % 41 66 % 0.019 23 (24 %) 7 (7 %) 41 (43 %) 3 (3 %) 9 (9 %) 53 (55 %)
BDT Bangladesh Taka. Median Patient cost 8,200BDT. High Income defined as >1935BDT / week
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in Tanzania, where 40 % of dissavers did not take out
loans. The difference in mean income between those
reporting ‘low’ versus ‘extreme’ costs in the Bangalore
dataset was only 20 % (Table 3), and the relationship be-
tween income and cost band was not statistically signifi-
cant (p = 0.13). Income levels were reported by 62 % of
respondents in Tanzania and 67 % of respondents in
Bangladesh. Although the questionnaires offered respon-
dents a choice of 4 income bands, only four respondents
in Bangladesh and six respondents in Tanzania reported
incomes in the higher two bands. We therefore aggregated
the higher three levels in the stratification analysis, divid-
ing respondents into low and high income, using the
upper limit of the lowest income band in the question-
naires as the threshold (1935 BDT per week in Bangladesh
and 20,000TZS per week in Tanzania). Higher income
was associated with cost level in both countries at the
10 % significance level (Bangladesh p = 0.08, Tanzania
p = 0.07).
Results from logistic regressions to predict the prob-
ability of dissaving are given in Table 4. In Tanzania,
dissaving was significantly positively associated with cost
(p = 0.03) and male gender (p = 0.005). In Bangladesh,
these variables were also positively associated with
dissaving, but not significantly. No other variables were
significantly associated with dissaving in either location.
We carried out a similar analysis for Bangalore, with
predictors similar except for the lack of rural patients,
the availability of income data, and the characterisation
of SES as a 3-level factor. We found significant positive
associations between the presence of dissaving and cost
(p = 0.005), hospitalisation (p < 0.001), and low socioeco-
nomic level (p = 0.011). There was a significant negative
association between dissaving and income (p < 0.001).
We then explored the association between patient cost
and the amount of dissaving among the subset of pa-
tients (57 in Tanzania, 53 in Bangladesh and 332 in
Bangalore) who reported dissaving at any amount
(Table 5). We found a significant positive relationship
between costs and dissaving, after allowing for factors
such as income, socioeconomic status and hospitalisation,
for Bangladesh (p < 0.001) and Bangalore (p < 0.001). The
relationship for Tanzania was positive but not significant
(p = 0.201).
Of the 891 Bangalore respondents reporting cost and
income, 762 (86 %) reported costs greater than 20 % of
annual income, and 661 (74 %) reported costs greater
than 40 % of total annual income. There was a significant
Table 2 Information on dissaving and patient characteristics for Tanzania tuberculosis patients, stratified by cost band
Cost
band
Definition No. Mean patient
cost (000 s TZS)
%
Rural
Mean
age
%
Male
Mean SES
score
% Reporting
high income
%
Hospitalised
No. dissaving
Loan Sale Both All
Low <100 %
of median
47 139 41 % 37 60 % 0.246 7 (15 %) 4 (9 %) 7 (15 %) 11 (23 %) 5 (11 %) 23 (49 %)
Medium 100–200 %
of median
28 294 50 % 39 54 % 0.249 7 (25 %) 4 (14 %) 3 (11 %) 8 (29 %) 8 (29 %) 19 (68 %)
High 200–300 %
of median
10 544 60 % 42 80 % 0.042 3 (30 %) 3 (30 %) 0 (0 %) 1 (10 %) 5 (50 %) 6 (60 %)
Extreme >300 %
of median
9 1053 22 % 44 67 % 0.204 5 (55 %) 7 (78 %) 3 (33 %) 3 (33 %) 3 (33 %) 9 (100 %)
All Any cost
level
94 323 44 % 39 66 % 0.221 22 (23 %) 18 (19 %) 13 (14 %) 23 (24 %) 21 (22 %) 57 (61 %)
TZS Tanzania Shilling. Median Patient cost 230,000TZS. High Income defined as >20,000TZS / week
Table 3 Information on dissaving and patient characteristics for Bangalore tuberculosis patients, stratified by cost band
Cost
band
Definition No. Mean patient
cost (INR)
Mean income
(INR / yr)
Mean
age
%
Male
% Low
SES
%
Hospitalised
No. dissaving
Loan Sale Both All
Low <100 % of
median
445 1700 4900 33 51 % 51 % 20 % 69 (16 %) 6 (1 %) 8 (2 %) 83 (19 %)
Medium 100–200 %
of median
191 5800 5700 35 59 % 51 % 48 % 73 (38 %) 6 (3 %) 9 (5 %) 88 (46 %)
High 200–300 %
of median
98 9700 5400 35 63 % 49 % 65 % 45 (46 %) 3 (3 %) 8 (8 %) 56 (57 %)
Extreme >300 %
of median
157 24,000 5800 35 74 % 38 % 78 % 79 (50 %) 3 (2 %) 23 (15 %) 105 (67 %)
All Any cost
level
891 7400 5300 35 59 % 42 % 266 (30 %) 18 (2 %) 48 (5 %) 332 (37 %)
INR Indian Rupee. Median patient cost 4000INR
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positive relationship between dissaving and the ratio of
cost to income, after allowing for age, gender, socioeco-
nomic status and reported hospitalisation (Table 6). An in-
crease in dissaving of $10 was associated with an increase
in the cost-income ratio of 0.10 (p < 0.001). Table 7 pre-
sents the results from cost regressions stratified by income
band in Bangladesh and Tanzania. Results are presented
for those participants who provided their income band
(Table 7a), and for all participants (Table 7b). The latter
were calculated by imputing missing income bands from
other participant characteristics (age, gender, location, SES
and hospitalisation). Among Bangladeshi low-income dis-
savers, each $10 increase in dissaving was associated with
higher costs of $7 (p < 0.001). There was no statistically
significant relationship between the level of dissaving and
patient costs among high-income Bangladeshis, high-
income Tanzanians, or low-income Tanzanians. These re-
sults were robust to the method used for analysis in the
presence of missing data (complete case analysis or imput-
ation of income bands).
Discussion
The measurement of costs and income involves numer-
ous challenges. Dissaving is, by comparison, easier to
measure, indicates by definition a financial weakening of
a household, and is a widely-used coping strategy [18]. It
is therefore a potential proxy for catastrophic costs in
routine monitoring and evaluation. We analyse the link
between dissaving, costs, income, and catastrophic costs,
using data collected in three countries across two conti-
nents,. The first part of our analysis explores the link be-
tween extreme cost and several potential explanatory
variables, including dissaving. Our motivation was that
cost distributions are commonly ‘fat-tailed’, reflecting
high prevalence of ‘extreme’ costs likely to lead to finan-
cial hardship. We use median cost as a yardstick to iden-
tify extreme costs as it is simple to calculate and reflects
costs typically faced by others in the same location.
Hospitalisation was associated with extreme costs in
Bangalore, and with high/extreme costs in Tanzania,
Bangladesh, which had the lowest rate of hospitalisation,
Table 4 Coefficients for logistic regression models predicting likelihood of dissaving of any amount
Mean (se) coefficient values
Predictors Tanzania (N = 96) Bangladesh (N = 94) Bangalore (N = 891)
Intercept 2.370e + 00 (1.268e + 00) 1.793e + 00 (1.473e + 00) −1.220e + 00 (4.378e-01)**
Total cost 2.929e-06 (1.347e-06)* 4.001e-05 (3.687e-05) 7.844e-05 (1.192e-05)***
Age −2.922e-02 (1.956e-02) −2.239e-02 (1.393e-02) −1.192e-04 (2.895e-05)
Female gender −1.552e + 00 (5.479e-01)** −6.049e-01 (4.677e-01) −7.655e-03 (5.494e-03)
Hospitalisation −6.382e-01 (7.796e-01) −1.095e + 00 (1.175e + 00) 7.995e-01 (1.684e-01)***
Rural location −3.299e-01 (5.091e-01) 6.742e-01 (8.317e-01) NA
SES −1.068e + 00 (6.869e-01) −7.520e-01 (6.295e-01) NA
Low SES NA NA 8.800e-01 (3.488e-01)*
Medium SES NA NA 4.240e-01 (3.371e-01)
Income NA NA −1.192e-04 (2.895e-05)***
‘***’p = 0.001 ‘**’p = 0.01 ‘*’p = 0.05
Table 5 Coefficients for linear regression models predicting total costs for patients who dissave
Mean (se) coefficient values
Predictors Tanzania N = 57 Bangladesh N = 53 Bangalore N = 332
Intercept 3.043e + 05 (1.630e + 05) 1.889e + 04 (8.133e + 03)* 1.036e + 04 (2.977e + 03)***
Dissaving amount 2.181e-01 (1.684e-01) 6.779e-01 (6.212e-02)*** 7.648e-01 (6.057e-02)***
Age −7.726e + 01 (1.313e + 02) −7.726e + 01 (1.313e + 02) −7.041e + 01 (4.033e + 01)
Female gender 8.589e + 03 (4.410e + 03) 8.589e + 03 (4.410e + 03) 2.815e + 03 (1.126e + 03)*
Hospitalisation −3.896e + 05 (8.473e + 04)*** −1.431e + 04 (6.368e + 03)* 3.201e + 03 (1.140e + 03)**
Rural location 1.609e + 05 (7.900e + 04)* −7.219e + 03 (7.410e + 03) NA
SES −2.195e + 05 (1.251e + 05) 1.056e + 04 (5.116e + 03)* NA
Low SES NA NA −8.996e + 03 (2.431e + 03)***
Medium SES NA NA −8.679e + 03 (2.382e + 03)***
Income NA NA 5.759e-01 (2.089e-01)**
‘***’p = 0.001 ‘**’p = 0.01 ‘*’p = 0.05
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also had the lowest prevalence of extreme costs. This
suggests that that service delivery models minimising
hospitalisation should be prioritised, and financial pro-
tection offered when hospitalisation is unavoidable,
which is consistent with previous findings that inefficient
patient management can be a major cause of catastrophic
health expenditure [1]. Income was not associated
with extreme costs in Bangalore or high/extreme costs
in Tanzania. Even in Bangladesh, where there was an as-
sociation between high/extreme cost and income band,
two of the three respondents reporting extreme costs
also reported low income. Dissaving (at any level) was
associated with extreme costs in Bangalore, but the
relationship between dissaving and cost band was not
significant in other locations. This may be due to the
sample size, but might also be related to the fact that
dissaving was more prevalent in Bangladesh (53 %) and
Tanzania (61 %) than in Bangalore (37 %). Monitoring
whether or not TB patients dissave is less likely to be
sufficient in locations where it is commonplace.
There are two concerns with benchmarking against
median costs as a tool for monitoring and evaluation.
Firstly, interventions to reduce median costs will reduce
the absolute value of thresholds based on it. A solution
to this might be to benchmark against a stable measure
such as a pre-defined context-specific measure of costs
reflecting what is tolerable by poor households. Sec-
ondly, this does not take income, and hence ability to
pay, into account. Our analysis suggests this may not be
a major concern, since income is not strongly associated
with cost, although this may not be true in every setting.
All 157 respondents reporting extreme costs in Bangalore
also reported a cost/income ratio greater than 40 %.
Table 6 Coefficients for linear regression model predicting
cost-income ratios for Bangalore patients who dissaved
Predictors Mean (se) coefficient values
Intercept 1.263e + 00 (9.024e-01)
Dissaving amount 2.279e-04 (2.176e-05)***
Age 2.025e-04 (1.454e-02)
Female gender 5.483e-01 (4.056e-01)
Hospitalisation 9.420e-01 (4.113e-01)*
Low SES −1.914e-01 (8.065e-01)
Medium SES −1.051e + 00 (8.267e-01)
‘***’p = 0.001 ‘*’p = 0.05
Table 7 Linear regression model coefficients predicting total patient cost by income band for those who dissaved
a: Complete case analysis
Mean (se) coefficient values
Tanzania Bangladesh
Predictors Income < 20,000TZS / week Income > 20,000TZS / week Income < 1935 BDT / week Income > 1935 BDT / week
N = 23 N = 16 N = 25 N = 11
Intercept 1.376e + 05 (1.435e + 05) −1.466e + 05 (1.047e + 06) 1.170e + 04 (1.373e + 04) 2.591e + 04 (1.075e + 04)
Dissaving amount 9.507e-02 (1.565e-01) 4.619e-01 (5.965e-01) 7.073e-01 (8.668e-02)*** 2.763e-02 (1.192e-01)
Age 1.600e + 03 (3.048e + 03) 1.664e + 04 (1.736e + 04) −3.163e + 01 (2.281e + 02) 6.530e + 01 (3.257e + 02)
Female gender −3.683e + 04 (2.074e + 05) 1.517e + 05 (3.533e + 05) 1.823e + 04 (1.136e + 04) NA
Hospitalisation NA −2.868e + 05 (3.977e + 05) −1.362e + 04 (9.631e + 03) −3.507e + 03 (8.264e + 03)
Rural location 3.749e + 04 (8.546e + 04) 2.933e + 05 (2.893e + 05) 7.289e + 03 (1.265e + 04) −3.016e + 04 (7.867e + 03)*
SES 1.879e + 04 (1.743e + 05) −4.369e + 05 (2.798e + 05) 3.940e + 03 (8.415e + 03) 1.728e + 04 (6.022e + 03)*
b: Analysis with imputation of missing income band from participant characteristics (age, gender, location, SES and hospitalisation)
Mean (se) coefficient values
Tanzania Bangladesh
Predictors Income < 20,000TZS / week Income > 20,000TZS / week Income < 1935 BDT / week Income > 1935 BDT / week
N = 35 N = 23 N = 41 N = 12
Intercept 4.020e + 05 2.804e + 05 −6.513e + 05 5.874e + 05 9.205e + 03 (8.980e + 03) 2.091e + 04 (1.130e + 04)
Dissaving amount 7.359e-02 1.889e-01 4.792e-01 3.782e-01 7.634e-01 (6.476e-02)*** 3.834e-02 (1.314e-01)
Age 1.152e + 03 3.386e + 03 1.712e + 04 9.020e + 03 −1.810e + 01 (1.384e + 02) 2.778e + 02 (3.248e + 02)
Female gender −6.014e + 04 1.152e + 05 4.260e + 04 1.946e + 05 7.789e + 03 (4.779e + 03) NA
Hospitalisation NA 3.338e + 05 1.782e + 05 −1.107e + 04 (6.978e + 03) −7.406e + 03 (8.675e + 03)
Rural location −6.015e + 04 1.032e + 05 1.902e + 05 1.857e + 05 2.243e + 03 (8.193e + 03) −2.783e + 04 (8.520e + 03)*
SES −7.030e + 04 1.883e + 05 −3.359e + 05 2.035e + 05 4.261e + 03 (5.506e + 03) 1.805e + 04 (6.626e + 03)*
‘***’p = 0.001 ‘*’p = 0.05
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Households facing ‘extreme’ costs are therefore largely a
subset of those facing catastrophic costs; identifying and
addressing drivers of ‘extreme’ costs (other than income
variation) can therefore be seen as a stepping-stone to-
wards the goal of eliminating catastrophic costs entirely.
We found consistent evidence of associations between
cost-income ratios and both the presence and level of
dissaving. In Bangalore, the probability of dissaving in-
creased with costs and decreased with income, and there
was a strong association between the amount of dissaving
and the cost-income ratio, which supports using the
former as a proxy for catastrophic costs. Evidence from
Bangladesh and Tanzania was less conclusive, largely be-
cause these were smaller studies, and collected income
data as bands rather than actual amounts. Even so, there
were several statistically significant associations consistent
with a relationship between dissaving and catastrophic
cost, and none inconsistent with such a relationship. How-
ever, the sample size and lack of precise values for income
are limitations, as is the fact that none of the studies
whose data we used were explicitly designed to evaluate
the use of dissaving as a proxy for catastrophic costs. In
particular, data from Bangladesh and Tanzania are not
available for the first 2 months of the continuation phase
(months 3 and 4). This is more likely to be a significant
issue for calculating dissaving than costs, as little is known
about the timing of asset sales and uptake of loans,
whereas it is more reasonable to assume that costs are
spread evenly throughout the continuation phase. Given
these limitations, further research is required to validate
the use of dissaving as an indicator of catastrophic costs,
and to explore the timing of dissaving relative to the in-
curring of costs. Further evidence is also required on how
universally dissaving measures could be applied – in some
settings, for example, there may be cultural barriers to the
take-up or reporting of loans.
Our analysis suggests that dissaving can be a useful
indicator in the evaluation and monitoring of financial
protection and service delivery interventions aimed at
reducing catastrophic costs. Further evidence would in-
form how this indicator is used – we expect it will
supplement other measures of financial distress where
available. Such measures could be used in combination
to identify catastrophic costs, for example by comparing
the amount of dissaving to the total amount of health-
care expenditure, using empirically determined thresholds.
Dissaving may also capture financial distress that is not
reflected in cost-income ratios, for example when house-
holds face multiple illnesses that are catastrophic together
but not singly [6].
Our results also illustrate different strategies for dis-
saving – dissavers in Tanzania, for example, were more
likely to sell assets than in Bangladesh or Bangalore. It is
likely that the nature of dissaving will influence its
relationship to financial hardship. It may therefore be
useful to distinguish between types of dissaving when
using this measure as a signal for financial distress. For
example, it may be possible to distinguish between
‘planned dissaving’ and ‘distressed dissaving’. The former
would involve measures designed for protecting house-
holds from financial shocks (e.g. cash savings, jewellery,
or low-interest loans). The latter would involve dissaving
actions that households adopt due to a lack of alterna-
tives, despite significant immediate consequences for
household well-being. Those who take out high-interest
loans, or sell assets that generated a high proportion of
household income, for example, would seem to be at
greatest risk of failing to meet basic subsistence needs as
a result. A further aim for future research would be to
explore the relationship between the type of dissaving
and the consequences for household wellbeing, in order
to enhance the value of dissaving measures as an indicator
of catastrophic cost.
Conclusion
Diseases such as TB, which disproportionately affect
poor households, can have a devastating effect on the fi-
nancial security of those households. The costs incurred
in relation to TB have been shown to appear early in the
care-seeking pathway, and this has a direct impact on
patient health, as it restricts the ability to access and
adhere to subsequent care [3, 22]. Dissaving is an infor-
mative indicator of financial hardship, and a convenient
potential proxy for catastrophic costs. It does not require
usage of complex patient questionnaires, making it a
particularly suitable indicator for routine monitoring
and evaluation. It is likely that instruments to assess dis-
saving could be used across a wide range of illnesses
with minimal alteration, whereas patient cost question-
naires require substantial adaptation to reflect specific
care-seeking and treatment pathways. Further research
is required to understand the patterns and types of dis-
saving that have the strongest relationship with financial
hardship.
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